MedTrace Logo

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

NCT02064673 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2026-03-30

No results posted yet for this study

Summary

This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.

Conditions

Interventions

DRUG

Curcumin

Curcumin or placebo 500mg by mouth twice a day for 6 months

DRUG

placebo

placebo orally twice a day

Sponsors & Collaborators

  • yair lotan

    lead OTHER

Principal Investigators

  • Yair Lotan, MD · University of Texas Southwestern Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2028-06-30
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02064673 on ClinicalTrials.gov